John M. Warrington

440 total citations
8 papers, 118 citations indexed

About

John M. Warrington is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, John M. Warrington has authored 8 papers receiving a total of 118 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 5 papers in Immunology and 3 papers in Molecular Biology. Recurrent topics in John M. Warrington's work include CAR-T cell therapy research (5 papers), Immune Cell Function and Interaction (4 papers) and Nanowire Synthesis and Applications (2 papers). John M. Warrington is often cited by papers focused on CAR-T cell therapy research (5 papers), Immune Cell Function and Interaction (4 papers) and Nanowire Synthesis and Applications (2 papers). John M. Warrington collaborates with scholars based in United States, Canada and Germany. John M. Warrington's co-authors include John M. Maris, Mark Yarmarkovich, Alvin Farrel, Nathan Singh, Amanda Heard, Jufang Chang, Matthew D. Weitzman, Marco Ruella, Abby M. Green and Katharina E. Hayer and has published in prestigious journals such as Nature Communications, Blood and Cancer Discovery.

In The Last Decade

John M. Warrington

7 papers receiving 118 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John M. Warrington United States	5	61	50	39	38	13	8	118
Savannah E. Butler United States	5	53 0.9×	62 1.2×	38 1.0×	42 1.1×	16 1.2×	10	171
Xizhou Zhu United States	6	61 1.0×	22 0.4×	39 1.0×	72 1.9×	7 0.5×	14	132
Luisanna Pia United States	5	28 0.5×	54 1.1×	57 1.5×	66 1.7×	23 1.8×	5	166
Aaron Wall United Kingdom	6	76 1.2×	55 1.1×	42 1.1×	87 2.3×	2 0.2×	8	165
Pedro Martínez‐Fleta Spain	8	60 1.0×	85 1.7×	17 0.4×	36 0.9×	13 1.0×	12	161
Krishnan Harinivas Harshan India	8	76 1.2×	100 2.0×	16 0.4×	41 1.1×	10 0.8×	20	201
Aner Ottolenghi Israel	8	104 1.7×	119 2.4×	62 1.6×	51 1.3×	69 5.3×	14	257
Chengcheng Fan United States	6	64 1.0×	45 0.9×	30 0.8×	12 0.3×	6 0.5×	9	134
Kathleen E. Huie United States	4	49 0.8×	16 0.3×	25 0.6×	51 1.3×	58 4.5×	5	175
Swetha Raman Canada	8	83 1.4×	68 1.4×	24 0.6×	59 1.6×	3 0.2×	11	187

Countries citing papers authored by John M. Warrington

Since Specialization

Citations

This map shows the geographic impact of John M. Warrington's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John M. Warrington with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John M. Warrington more than expected).

Fields of papers citing papers by John M. Warrington

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John M. Warrington. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John M. Warrington. The network helps show where John M. Warrington may publish in the future.

Co-authorship network of co-authors of John M. Warrington

This figure shows the co-authorship network connecting the top 25 collaborators of John M. Warrington. A scholar is included among the top collaborators of John M. Warrington based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John M. Warrington. John M. Warrington is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Warrington, John M., Julie Ritchey, Michael Slade, et al.. (2024). Rational Protein Engineering to Enhance MHC-Independent T-cell Receptors. Cancer Discovery. 14(11). 2109–2121. 5 indexed citations

2.

Jadlowsky, Julie K., David H. Spencer, John M. Warrington, et al.. (2024). Regulatory Considerations for Genome-Edited T-cell Therapies. Cancer Immunology Research. 12(9). 1132–1135. 2 indexed citations

3.

Heard, Amanda, et al.. (2023). Regulation of the Transcriptional Repressor BACH2 Overcomes Tonic Signaling-Driven CAR T Cell Dysfunction. Blood. 142(Supplement 1). 2065–2065.

4.

Heard, Amanda, John M. Warrington, John Lattin, et al.. (2022). Antigen glycosylation regulates efficacy of CAR T cells targeting CD19. Nature Communications. 13(1). 3367–3367. 40 indexed citations

5.

Makena, Monish Ram, Nanami Senoo, Donna K. Dang, et al.. (2022). Secretory pathway Ca2+-ATPase SPCA2 regulates mitochondrial respiration and DNA damage response through store-independent calcium entry. Redox Biology. 50. 102240–102240. 10 indexed citations

6.

Heard, Amanda, Jufang Chang, John M. Warrington, & Nathan Singh. (2021). Advances in CAR design. Best Practice & Research Clinical Haematology. 34(3). 101304–101304. 4 indexed citations

7.

Yarmarkovich, Mark, John M. Warrington, Alvin Farrel, & John M. Maris. (2020). Identification of SARS-CoV-2 Vaccine Epitopes Predicted to Induce Long-Term Population-Scale Immunity. Cell Reports Medicine. 1(3). 100036–100036. 56 indexed citations

8.

Warrington, John M., Yoko Kosaka, Iván Díaz-Padilla, et al.. (2018). Human ascites does not affect NK-92 cytotoxicity and intraperitoneal compared with intravenous administration of NK-92 shows superior survival in human ovarian cancer xenografted mice. Cytotherapy. 20(5). S106–S106. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact